Rybelsus 14 mg: the highest dose
The short answer
Rybelsus 14 mg once daily is the highest dose on the FDA label's schedule. It's allowed on day 61 or later, after 30 days each on 3 mg and 7 mg, if additional glycemic control is needed. If you have commercial insurance that covers Rybelsus, the savings offer is as little as $25.
Key takeaways
- Rybelsus 14 mg is the highest dose, allowed from day 61 only if more glycemic control is needed.
- If 7 mg is controlling your blood sugar, the label has you continue it.
- The dose is one 14 mg tablet. The label says no more than one tablet per day.
- With commercial insurance that covers Rybelsus, the savings offer is as little as $25.
- The label says most nausea, vomiting and diarrhea came during step-ups, which here means the weeks after day 61.
What the label says about Rybelsus 14 mg
Once dailyA labelled maintenance dose
From day 61 onward if additional glycemic control is needed.
On Day 61 or thereafter, if: Additional glycemic control is needed, increase the dosage to 14 mg orally once daily.
Comes as: Tablet (once daily).
FDA label: Revised: 1/2026 (DailyMed version 14)
Rybelsus dose schedule from the label
RybelsusRevised: 1/2026 (DailyMed version 14)
- 13 mg30 daysStart
- 27 mg30 daysMaintenance dose
- 314 mgongoingThis page
Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.
Supply per fill
| Form | Doses per device | Doses per fill | Days per fill | Fills per year |
|---|---|---|---|---|
| Tablet (once daily) | 1 | 30 | 30 | 12 |
Track run-out and refill dates with the supply tracker.
Rybelsus 14 mg: every way to pay, cheapest first
This table uses the 14 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.
| How you pay | Form | Per fill | Cost per mg | Conditions | Source |
|---|---|---|---|---|---|
| Manufacturer savings card | Tablet (once daily) | $25 | $0.06 | ConditionsCommercially insured patients with coverage for Rybelsus. Pay as little as $25 for a 1-, 2- or 3-month prescription of 7 mg or 14 mg (the 3 mg dose is $25 each month); maximum savings $100 per 1-month, $200 per 2-month or $300 per 3-month supply. Eligibility and restrictions apply. Note: Novo Nordisk states Rybelsus is being replaced by the Ozempic pill and existing Rybelsus savings offers can be used for Ozempic. | rybelsus.com |
Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.
If you miss a dose of Rybelsus
If you miss a daily tablet, skip it and take your next tablet the next morning; do not double up.
If a dose is missed, skip the missed dose and take the next dose the following day.
Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.
Fourteen milligrams is the top Rybelsus strength. The label reserves it for people who need more blood sugar control than 7 mg gives, and it’s the dose used in the label’s cardiovascular trial. The Rybelsus guide covers everything else.
The condition for 14 mg
The label’s text: on day 61 or thereafter, if additional glycemic control is needed, increase the dosage to 14 mg orally once daily. Glycemic control means blood sugar control. That sentence holds two requirements. Time: the 30 days on 3 mg and 30 days on 7 mg are complete. And need: 7 mg hasn’t been enough.
There’s no step beyond it. 14 mg is the highest dose on the schedule, and our label record classes it as a maintenance dose, a dose you stay on. The titration schedule tool shows the earliest date, and the dosing guide explains how prescribers decide on a final increase.
What the label reports at 14 mg
In the label’s trials, the higher dose brought more effect and more side effects. HbA1c is a blood test that measures average blood sugar.
- Blood sugar. HbA1c changed by -1.4% with 14 mg in the 26-week monotherapy trial, which tested Rybelsus used alone, against -1.2% with 7 mg and -0.3% with placebo (an inactive treatment).
- Heart. Trial 7, with 9,650 patients followed for a median of about 49.6 months, tested semaglutide tablets 14 mg. Major adverse cardiovascular events (serious heart and blood vessel events) were reduced, with a hazard ratio, a comparison of risk between groups, of 0.86 (12% versus 13.8% with placebo).
- Gastrointestinal reactions. Stomach and gut reactions occurred in 41% of patients on 14 mg, compared with 32% on 7 mg and 21% on placebo. Nausea was reported by 20 percent on 14 mg and 11 percent on 7 mg.
- Stopping treatment. 8% of patients on 14 mg discontinued because of gastrointestinal reactions, against 4% on 7 mg.
The label adds that most nausea, vomiting and diarrhea were reported during dose escalation, while the dose was being stepped up. For this strength, that means the weeks after day 61.
Supply, and the one-tablet rule
A bottle holds 30 tablets of 14 mg, a 30-day supply, and a year is 12 bottles. The label says not to take more than one tablet per day. So the 14 mg dose is one 14 mg tablet, and moving up means filling a new strength, not doubling the old one.
Price at 14 mg
The price is the same one that applies to the other strengths: the savings offer, as little as $25 for a 1-, 2- or 3-month prescription when commercial insurance covers Rybelsus. Under the offer, the lowest price is the same for 7 mg and 14 mg, so moving up doesn’t change it.
Since 14 mg is a settled long-term dose for those who reach it, ask whether your plan allows a 3-month prescription. The Rybelsus cost page covers insurance, cash and Medicare in turn. If you’re on Medicare, you can’t use the savings offer, and your cost follows your Part D plan.
How 14 mg relates to other products
Rybelsus exists only as a tablet. On the shared label, our switching record pairs Rybelsus 14 mg with Ozempic tablets 9 mg, and the label says the two are not substitutable on a mg-to-mg basis. Patients on the Ozempic 0.5 mg injection can also be moved to Rybelsus 7 mg or 14 mg. Both are decisions for your prescriber, and the switching planner shows what each label says.
Where to get Rybelsus
1. Manufacturer savings card
$25 per fill at 14 mg
Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.
Frequently asked questions
When do you go up to Rybelsus 14 mg?
The label allows it on day 61 or after, and only if additional glycemic control is needed. That means at least 30 days on 3 mg and 30 days on 7 mg first. If 7 mg is controlling your blood sugar, the label has you continue it. Your prescriber decides.
Can I take two Rybelsus 7 mg tablets instead of one 14 mg?
The label says not to take more than one tablet per day, so it doesn't provide for making up 14 mg from two 7 mg tablets. A move to 14 mg means a new prescription for the 14 mg strength. Ask your pharmacist what to do with any 7 mg tablets you have left.
Is Rybelsus 14 mg harder on the stomach than 7 mg?
The label's figures point that way. Gastrointestinal (stomach and gut) reactions occurred in 41% of patients on 14 mg and 32% on 7 mg in the pooled placebo-controlled trials. And 8% on 14 mg stopped treatment because of them, compared with 4% on 7 mg and 1% on placebo.
How much more does Rybelsus 14 mg lower A1c than 7 mg?
In the label's 26-week monotherapy trial (Rybelsus used alone), HbA1c changed by -1.4% with 14 mg and -1.2% with 7 mg, versus -0.3% with placebo. Against sitagliptin 100 mg at 26 weeks, the change was -1.3% with 14 mg and -1% with 7 mg, versus -0.8%.
What Ozempic tablet matches Rybelsus 14 mg?
According to our switching record of the shared label, Rybelsus 14 mg corresponds to Ozempic tablets 9 mg. The label is explicit that the products aren't substitutable on a mg-to-mg basis, so 14 mg of one isn't 14 mg of the other. A switch needs your prescriber.
Sources (8)
- 1.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 14.2, Table 4
“resulted in a statistically significant reduction in HbA1c compared with placebo (see Table 4).”
- 2.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 14.3, Table 6
“Treatment with semaglutide tablets 7 mg and semaglutide tablets 14 mg once daily for 26 weeks resulted in a statistically significant reduction in HbA1c compared to sitagliptin 100 mg once daily (see Table 6).”
- 3.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 14.4
“Semaglutide tablets significantly reduced the occurrence of MACE. The estimated hazard ratio for time to first MACE was 0.86 (95% CI: 0.77, 0.96) over the median follow-up duration of 49.6 months and 49.4 months for patients randomized to RYBELSUS and placebo, respectively.”
- 4.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Do not take more than one tablet per day.”
- 5.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.4
“One week after discontinuing 0.5 mg of subcutaneous OZEMPIC injection, start 7 mg or 14 mg of RYBELSUS orally once daily.”
- 6.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“RYBELSUS and OZEMPIC tablets are not substitutable on a mg-to-mg basis.”
- 7.
- 8.
